Patient information
了解Profil的新动态。
在该页面上您可以找到有关Profil的当前新闻。您可以阅读有关Profil以及作为临床研究组织,与我们工作相关的更多信息。此外,我们还将讨论糖尿病创新领域相关制药或技术公司高度关注的有趣话题。
如有任何疑问或意见,请随时使用右侧的联系按钮与我们联系。
Lars Bochmann 博士
市场与业务发展执行总监
二月 23, 2023
The IDF School of Diabetes offers a complimentary online course about Biosimilar Insulins, which is co-authored by Profil's Co-Founder and Lead Scientist Dr. Tim Heise. You can also find Profil's
read more
二月 14, 2023
In January 31st, the Clinical Trials Information System (CTIS) became the single entry point for submitting clinical trials in the European Union. Exactly one year before the one-year transition
十二月 22, 2022
Chronological Milestones of the CTR The ‘Clinical Trials Regulation’ (CTR) came into force on 27 May 2014 on condition that there was an EU-wide portal prepared, audited and found to be functional
十二月 20, 2022
Dear all, Greetings from Germany! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity. Profil
十二月 2, 2022
PubMed Central, the free full-text archive of biomedical and life sciences journal literature at the U.S. National Institutes of Health’s National Library of Medicine (NIH/NLM) lists 163 publications
十一月 8, 2022
We are happy to announce that our successful series of scientific online seminars continues. On December 07th, 2022 at 6 PM CET we will air our next complimentary live online seminar. The session is
十一月 2, 2022
For patients with type 1 diabetes, continuous subcutaneous insulin infusion (CSII) is a common therapy and represents a concept that, when compared to therapy with multiple daily injections, is
九月 29, 2022
Aim of the study SURMOUNT-1 [1] evaluated the efficacy and safety of tirzepatide in adults with obesity or overweight without diabetes. Gewichtsverlust / Diäterfolg dank Pillen – Tabletten, Kapseln
九月 28, 2022
Dear all, Greetings from Germany! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity. On-demand